RNA Clinical Trials Resources

31. Oesophageal Cancer: Global Clinical Trial Landscape (2024) 8/19/2024

    Oesophageal cancer is the 11th most common cancer and the 7th leading cause of cancer deaths, starting in the esophagus. Explore our report to discover the latest in treatments, clinical trials, and future innovations.

32. FAQs – RNA Therapies – Global Clinical Trials Landscape (2024) 8/19/2024

    Whether you’re a researcher, clinician, or industry professional, our FAQs will equip you with essential knowledge on the advancements and challenges in RNA therapy development.

33. A Global Trials Overview Of Oesophageal Cancer In 2024 8/19/2024

    This FAQ delves into the latest advancements in the treatment of oesophageal cancer, highlighting cutting-edge drugs, ongoing clinical trials, and their potential to improve patient outcomes.

34. Strategies For A More Secure Outsourcing Bottom Line 7/9/2024

    A panel of experts from across the pharmaceutical/biopharmaceutical industry recently shared their experiences in mitigating financial risk before partnering with a contract research organization (CRO).

35. How To Establish Effective, Scalable Drug Safety Ops Across Vendors 7/9/2024

    Numerous factors impact a drug safety program, but proper management of three key elements drives success while creating a scalable drug safety model.

36. Insights into Global Non-Small Cell Lung Cancer Research 7/3/2024

    This FAQ section delves into non-small cell lung cancer (NSCLC) incidence, current trials, innovative drugs, and their effects on patient outcomes.

37. A Global Overview Of Liver Cancer Clinical Studies 7/3/2024

    This FAQ examines advancements in liver cancer treatment, emphasizing innovative drugs, current clinical trials, and their potential effects on patient outcomes.

38. Non-Small Cell Lung Cancer — Global Clinical Trial Landscape (2024) 7/3/2024

    Explore cutting-edge Non-Small Cell Lung Cancer (NSCLC) research with Novotech CRO's in-depth disease analysis, providing insights into innovative therapies, clinical trials, and future directions shaping NSCLC care globally.

39. Liver Cancer — Global Clinical Trial Landscape (2024) 7/3/2024

    Explore the latest advancements and clinical trial landscape in liver cancer research with Novotech CRO's comprehensive disease report.

40. South Korea And Australia On The Rise As Clinical Research Hubs 7/3/2024

    Novotech’s vice president emphasizes the expanding clinical presence in the APAC region, with a focus on Australia and South Korea.